Abstract:Purpose: Breast cancer is the leading cause of cancer death worldwide in women. The molecular mechanism for human breast cancer is unknown. Gene microarray has been widely used in breast cancer research to identify clinically relevant molecular subtypes as well as to predict prognosis survival. So far, the valuable multigene signatures in clinical practice are unclear, and the biological importance of individual genes is difficult to detect, as the described signatures virtually do not overlap. Early prognosis of this disease, breast invasive ductal carcinoma (IDC) and breast ductal carcinoma in situ (DCIS), is vital in breast surgery.Methods: Thus, this study reports gene expression profiling in large breast cancer cohorts from Gene Expression Omnibus, including GSE29044 (N=138) and GSE10780 (N=185) test series and four independent validation series GSE21653 (N=266), GSE20685 (N=327), GSE26971 (N=276), and GSE12776 (N=204). Significantly differentially expressed genes in human breast IDC and breast DCIS were detected by transcriptome microarray analysis.Results: We created a set of three genes (MAMDC2, TSHZ2, and CLDN11) that were significantly correlated with disease-free survival of breast cancer patients using a univariate Cox regression model (significance level P<0.01) in a meta-analysis. Based on the risk score of the three genes, the test series patients could be separated into low-risk and high-risk groups with significantly different survival times. This signature was validated in the other three cohorts. The prognostic value of this three-gene signature was confirmed in the internal validation series and another four independent breast cancer data sets. The prognostic impact of one of the three genes, CLDN11, was confirmed by immunohistochemistry. CLDN11 was significantly overexpressed in human breast IDC as compared with normal breast tissues and breast DCIS.Conclusion: Using novel gene expression profiling together with a meta-analysis validation approach, we have identified a three-gene signature with independent prognostic impact. Furthermore, CLDN11 may offer a biomarker to predict prognosis as well as a new target for prognostic and therapeutic intervention for human breast IDC.

Analysis of Gene Differentially Expressed in Mice Breast Cancer by Cdna Microarray

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Study on Metastasis-Associated Gene in Carcinoma by Cdna Microarray

Comparative Gene Expression Analysis in Mouse Models for Identifying Critical Pathways in Mammary Gland Development

Cluster Analysis of Gene Expression and Glioblastoma-Associated Gene by Using Cdna Microarray

Identification of Differential Gene Expressions in Colorectal Cancer and Polyp by Cdna Microarray

Bioinformatic Analysis of Differentially Expressed Genes in Metastatic Melanoma

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

Expression and Function of Differentially Expressed Genes in Glioblas-Toma by Using Cdna Microarray

Analysis of differentially expressed genes between the high-metastatic and low-metastatic lung cancer cell lines

Analysis of Gene Expression Patterns in Pancreatic Cancer by Cdna Micro Array

Identification Of Differentially Expressed Genes Between Mucinous Adenocarcinoma And Other Adenocarcinoma Of Colorectal Cancer Using Bioinformatics Analysis

The use of microsatellite DNA markers for distinguishing metastatic tumor cells]

Analysis of Gene Expression Profiles in Pancreatic Carcinoma by Using Cdna Microarray.

[Cdna Microarray in the Gene Expression Pattern in Lymphatic Metastasis of Pancreatic Carcinoma].

Analysis of Related Gene Expression in Prostate Carcinoma by Cdna Microarray

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

[Differential Gene Expression Analysis of Human Leukemic Cell Line with Different Tumorigenic Potentials in Nude Mice].

MICROARRAY ANALYSIS OF DIFFERENT GENE EXPRESSION OF HUMAN CERVICAL CANCER SUBCLONE CELL LINES

Analyses on the differentially expressed genes associated with murine double minute 2/p53 pathway in breast cancer